Sign In
Buy MRNA
$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
Live Nasdaq Composite: Tech Shines as Relief Rally Proves It Has Legs
09:43am, Thursday, 22'nd Jan 2026
Live Updates Economy Expands 24 minutes ago Live The U.S. economy is humming along, thanks to a resilient consumer and robust capex spending in corporate America. The latest data have revealed that GD
What's Happening With Moderna Stock?
09:15am, Thursday, 22'nd Jan 2026
Moderna stock surged 16% yesterday after receiving promising clinical trial results for its experimental skin cancer vaccine. The firm is working on mRNA-1893/V940, a personalized cancer vaccine devel
Small-Cap Growth Without Dividends: What NUSC's 1.4 Beta Really Costs Investors
08:06am, Thursday, 22'nd Jan 2026
Small-cap stocks have historically rewarded patient investors willing to endure volatility in exchange for growth potential.
Moderna Stock Is Surging. Why a Cancer Vaccine Study Has Sparked a Rally.
06:27am, Thursday, 22'nd Jan 2026
Wall Street is hopeful that a pipeline of cancer drugs can drive earnings growth as the respiratory vaccine business flounders.
Stock Market Today: S&P 500, Dow Jones Futures Rise As Trump Scales Down EU Tariff Threats—Microsoft, Moderna, Intel In Focus
05:19am, Thursday, 22'nd Jan 2026
U.S. stock futures rose on Thursday following Wednesday's gains. Futures of major benchmark indices were higher.
Why Moderna Stock Surged Today
06:51pm, Wednesday, 21'st Jan 2026
Moderna's and Merck's partnership could help to advance cancer care. A promising skin cancer trial might have broader implications for other types of tumor treatments.
Live Nasdaq Composite: Markets Dodge Geopolitical Bullet as Optimism Returns
10:05am, Wednesday, 21'st Jan 2026
Live Updates Highs and Lows 19 minutes ago Live Netflix stock sunk to a new 52-week low today to below $82 per share. On the other side of the spectrum, AMD (Nasdaq: AMD) is soaring, up 8.5% on the da
Moderna (MRNA) Increases Despite Market Slip: Here's What You Need to Know
07:17pm, Tuesday, 20'th Jan 2026
Moderna (MRNA) closed at $43 in the latest trading session, marking a +2.8% move from the prior day.
Moderna Pops 17%—Is There Life in MRNA, Down 90% from COVID High?
03:31pm, Tuesday, 20'th Jan 2026
In a blast from the past, COVID-19 vaccine developer Moderna NASDAQ: MRNA just made headlines in 2026. Shares jumped up more than 17% on Jan. 13, Moderna's largest single-day up-move in over three yea
Moderna, Merck Report Positive Results From Cancer-Vaccine Study
06:58am, Tuesday, 20'th Jan 2026
Moderna and Merck's cancer vaccine reduced the risk of relapse or death for melanoma patients, five-year data from a Phase 2b trial showed.
Moderna, Merck's skin cancer vaccine shows sustained benefit after five years
06:25am, Tuesday, 20'th Jan 2026
Moderna and Merck said on Tuesday their experimental vaccine for a serious type of skin cancer, used in combination with Keytruda, reduced the risk of recurrence or death by 49% in a mid-stage trial.
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection
06:00am, Tuesday, 20'th Jan 2026
At a median five-year pre-planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA reduced the risk of recurrence or death by 49% (HR=0.510;
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Friday, 16'th Jan 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Moderna Stock on the Move: What Sparked the 13% Jump in the Past Week?
09:57am, Thursday, 15'th Jan 2026
MRNA shares rise after upbeat 2025 sales, stronger cash outlook and detailed 2026 guidance, alongside multiple pipeline milestones.
Moderna (MRNA) Increases Despite Market Slip: Here's What You Need to Know
06:51pm, Wednesday, 14'th Jan 2026
Moderna (MRNA) closed the most recent trading day at $40.6, moving +2.52% from the previous trading session.
